Sergio Rosini

Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Study on the Pharmacodynamics of ABIO-08/01, a New CNS Drug with Potential Anxiolytic Activity

Michael Wolzt, Bernd Saletu, Peter Anderer, 2009, Neuropsychobiology.